245 related articles for article (PubMed ID: 16498407)
1. Progressively impaired proteasomal capacity during terminal plasma cell differentiation.
Cenci S; Mezghrani A; Cascio P; Bianchi G; Cerruti F; Fra A; Lelouard H; Masciarelli S; Mattioli L; Oliva L; Orsi A; Pasqualetto E; Pierre P; Ruffato E; Tagliavacca L; Sitia R
EMBO J; 2006 Mar; 25(5):1104-13. PubMed ID: 16498407
[TBL] [Abstract][Full Text] [Related]
2. Dampening Ab responses using proteasome inhibitors following in vivo B cell activation.
Cascio P; Oliva L; Cerruti F; Mariani E; Pasqualetto E; Cenci S; Sitia R
Eur J Immunol; 2008 Mar; 38(3):658-67. PubMed ID: 18253932
[TBL] [Abstract][Full Text] [Related]
3. XBP-1 specifically promotes IgM synthesis and secretion, but is dispensable for degradation of glycoproteins in primary B cells.
Tirosh B; Iwakoshi NN; Glimcher LH; Ploegh HL
J Exp Med; 2005 Aug; 202(4):505-16. PubMed ID: 16103408
[TBL] [Abstract][Full Text] [Related]
4. Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.
Meister S; Schubert U; Neubert K; Herrmann K; Burger R; Gramatzki M; Hahn S; Schreiber S; Wilhelm S; Herrmann M; Jäck HM; Voll RE
Cancer Res; 2007 Feb; 67(4):1783-92. PubMed ID: 17308121
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin light chains dictate vesicular transport-dependent and -independent routes for IgM degradation by the ubiquitin-proteasome pathway.
Elkabetz Y; Kerem A; Tencer L; Winitz D; Kopito RR; Bar-Nun S
J Biol Chem; 2003 May; 278(21):18922-9. PubMed ID: 12754269
[TBL] [Abstract][Full Text] [Related]
6. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.
Roff M; Thompson J; Rodriguez MS; Jacque JM; Baleux F; Arenzana-Seisdedos F; Hay RT
J Biol Chem; 1996 Mar; 271(13):7844-50. PubMed ID: 8631829
[TBL] [Abstract][Full Text] [Related]
7. Regulatory mechanisms that determine the development and function of plasma cells.
Calame KL; Lin KI; Tunyaplin C
Annu Rev Immunol; 2003; 21():205-30. PubMed ID: 12524387
[TBL] [Abstract][Full Text] [Related]
8. A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.
Shumway SD; Miyamoto S
Biochem J; 2004 May; 380(Pt 1):173-80. PubMed ID: 14763901
[TBL] [Abstract][Full Text] [Related]
9. Unfolded protein response inducers tunicamycin and dithiothreitol promote myeloma cell differentiation mediated by XBP-1.
Jiang H; Zou J; Zhang H; Fu W; Zeng T; Huang H; Zhou F; Hou J
Clin Exp Med; 2015 Feb; 15(1):85-96. PubMed ID: 24356728
[TBL] [Abstract][Full Text] [Related]
10. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.
Cerutti A; Schaffer A; Goodwin RG; Shah S; Zan H; Ely S; Casali P
J Immunol; 2000 Jul; 165(2):786-94. PubMed ID: 10878352
[TBL] [Abstract][Full Text] [Related]
11. Xbp1s-negative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma.
Leung-Hagesteijn C; Erdmann N; Cheung G; Keats JJ; Stewart AK; Reece DE; Chung KC; Tiedemann RE
Cancer Cell; 2013 Sep; 24(3):289-304. PubMed ID: 24029229
[TBL] [Abstract][Full Text] [Related]
12. Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines.
Jiang H; Gao W; Sze DM; Xiong H; Hou J
Int J Hematol; 2007 Dec; 86(5):429-37. PubMed ID: 18192112
[TBL] [Abstract][Full Text] [Related]
13. Enhanced proteolysis of IkappaBalpha and IkappaBbeta proteins in astrocytes by Moloney murine leukemia virus (MoMuLV)-ts1 infection: a potential mechanism of NF-kappaB activation.
Kim HT; Qiang W; Wong PK; Stoica G
J Neurovirol; 2001 Oct; 7(5):466-75. PubMed ID: 11582519
[TBL] [Abstract][Full Text] [Related]
14. Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors.
Cenci S; Oliva L; Cerruti F; Milan E; Bianchi G; Raule M; Mezghrani A; Pasqualetto E; Sitia R; Cascio P
J Leukoc Biol; 2012 Nov; 92(5):921-31. PubMed ID: 22685320
[TBL] [Abstract][Full Text] [Related]
15. Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells.
Shapiro-Shelef M; Lin KI; McHeyzer-Williams LJ; Liao J; McHeyzer-Williams MG; Calame K
Immunity; 2003 Oct; 19(4):607-20. PubMed ID: 14563324
[TBL] [Abstract][Full Text] [Related]
16. Development of mKO2 fusion proteins for real-time imaging and mechanistic investigation of the degradation kinetics of human IκBα in living cells.
Rahimova N; Babazada H; Higuchi Y; Yamashita F; Hashida M
Biochim Biophys Acta Mol Cell Res; 2019 Feb; 1866(2):190-198. PubMed ID: 30391277
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor MIST1 in terminal differentiation of mouse and human plasma cells.
Capoccia BJ; Lennerz JK; Bredemeyer AJ; Klco JM; Frater JL; Mills JC
Physiol Genomics; 2011 Feb; 43(3):174-86. PubMed ID: 21098683
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated IkappaBalpha is a component of Lewy body of Parkinson's disease.
Noda K; Kitami T; Gai WP; Chegini F; Jensen PH; Fujimura T; Murayama K; Tanaka K; Mizuno Y; Hattori N
Biochem Biophys Res Commun; 2005 May; 331(1):309-17. PubMed ID: 15845394
[TBL] [Abstract][Full Text] [Related]
19. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells.
Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Ohta S; Hirai Y; Kimoto M; Miyake K; Takatsu K
Int Immunol; 2012 Jun; 24(6):389-400. PubMed ID: 22354914
[TBL] [Abstract][Full Text] [Related]
20. The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition.
Bianchi G; Oliva L; Cascio P; Pengo N; Fontana F; Cerruti F; Orsi A; Pasqualetto E; Mezghrani A; Calbi V; Palladini G; Giuliani N; Anderson KC; Sitia R; Cenci S
Blood; 2009 Mar; 113(13):3040-9. PubMed ID: 19164601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
